BioVariance uses machine learning and mathematical algorithms to analyze complex biomedical data and offer long-term monitoring of molecular changes in patients to predict the effectiveness, side effects, and drug interaction, thereby helping determine optimal medication and dosage. The company's multidisciplinary team works with physicians to generate testable hypotheses in the context of genetic and drug data to advance pharmaceutical research. Additionally, BioVariance is working on a software product that makes this knowledge accessible for the healthcare system, ensuring that all options are considered equally for drug treatments, as every patient is unique and so is their therapy.